Yan S - Search Results

1

Resident memory CD8⁺ T cells in regional lymph nodes mediate immunity to metastatic melanoma.

Molodtsov AK, Khatwani N, Vella JL, Lewis KA, Zhao Y, Han J, Sullivan DE, Searles TG, Preiss NK, Shabaneh TB, Zhang P, Hawkes AR, Malik BT, Kolling FW 4th, Usherwood EJ, Wong SL, Phillips JD, Shirai K, Angeles CV, Yan S, Curiel TJ, Huang YH, Cheng C, Turk MJ. Molodtsov AK, et al. Among authors: yan s. Immunity. 2021 Sep 14;54(9):2117-2132.e7. doi: 10.1016/j.immuni.2021.08.019. Immunity. 2021. PMID: 34525340 Free PMC article.

2

False-positive cells in sentinel lymph nodes.

Brennick JB, Yan S. Brennick JB, et al. Among authors: yan s. Semin Diagn Pathol. 2008 May;25(2):116-9. doi: 10.1053/j.semdp.2008.03.001. Semin Diagn Pathol. 2008. PMID: 18697715 Review.

3

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.

Whipple CA, Boni A, Fisher JL, Hampton TH, Tsongalis GJ, Mellinger DL, Yan S, Tafe LJ, Brinckerhoff CE, Turk MJ, Mullins DW, Fadul CE, Ernstoff MS. Whipple CA, et al. Among authors: yan s. Melanoma Res. 2016 Jun;26(3):223-35. doi: 10.1097/CMR.0000000000000244. Melanoma Res. 2016. PMID: 26974965

4

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.

Kuklinski LF, Yan S, Li Z, Fisher JL, Cheng C, Noelle RJ, Angeles CV, Turk MJ, Ernstoff MS. Kuklinski LF, et al. Among authors: yan s. Cancer Immunol Immunother. 2018 Jul;67(7):1113-1121. doi: 10.1007/s00262-018-2169-1. Epub 2018 May 8. Cancer Immunol Immunother. 2018. PMID: 29737375 Free PMC article.

5

Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.

LeBlanc RE, Barton DT, Li Z, Angeles CV, Ernstoff MS, Bagley E, Wimmer D, Wong SL, Barth RJ Jr, Shirai K, Yan S. LeBlanc RE, et al. Among authors: yan s. Am J Surg Pathol. 2019 Jun;43(6):755-765. doi: 10.1097/PAS.0000000000001229. Am J Surg Pathol. 2019. PMID: 31091203

6

Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.

Han J, Zhao Y, Shirai K, Molodtsov A, Kolling FW, Fisher JL, Zhang P, Yan S, Searles TG, Bader JM, Gui J, Cheng C, Ernstoff MS, Turk MJ, Angeles CV. Han J, et al. Among authors: yan s. Nat Cancer. 2021 Mar;2(3):300-311. doi: 10.1038/s43018-021-00180-1. Epub 2021 Mar 24. Nat Cancer. 2021. PMID: 34179824 Free PMC article.

7

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.

Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K. Palmer JP, et al. Among authors: yan s. Am J Case Rep. 2023 Nov 18;24:e938537. doi: 10.12659/AJCR.938537. Am J Case Rep. 2023. PMID: 37978795 Free PMC article.

8

False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes.

Yan S, Brennick JB. Yan S, et al. Am J Surg Pathol. 2004 May;28(5):596-600. doi: 10.1097/00000478-200405000-00005. Am J Surg Pathol. 2004. PMID: 15105646

9

Diagnostic and prognostic value of glucose transporters in melanocytic lesions.

Ruby KN, Liu CL, Li Z, Felty CC, Wells WA, Yan S. Ruby KN, et al. Among authors: yan s. Melanoma Res. 2019 Dec;29(6):603-611. doi: 10.1097/CMR.0000000000000626. Melanoma Res. 2019. PMID: 31135601

10

Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.

Yan S, Coffing BN, Li Z, Xie H, Brennick JB, Beg HA, Froehlich HM, Wells WA. Yan S, et al. Anticancer Res. 2016 Jun;36(6):2871-80. Anticancer Res. 2016. PMID: 27272799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,751 results

Search Page